Suppr超能文献

在美国具有正常葡萄糖耐量、糖尿病前期或糖尿病的非裔人群中 HbA 的表现:范围综述。

HbA Performance in African Descent Populations in the United States With Normal Glucose Tolerance, Prediabetes, or Diabetes: A Scoping Review.

机构信息

Department of Health and Nutrition Sciences, Brooklyn College, City University of New York, Brooklyn, New York.

College of Medicine, SUNY Downstate Health Sciences University, Brooklyn, New York.

出版信息

Prev Chronic Dis. 2021 Mar 11;18:E22. doi: 10.5888/pcd18.200365.

Abstract

INTRODUCTION

African descent populations in the United States have high rates of type 2 diabetes and are incorrectly represented as a single group. Current glycated hemoglobin A (HbA) cutoffs (5.7% to <6.5% for prediabetes; ≥6.5% for type 2 diabetes) may perform suboptimally in evaluating glycemic status among African descent groups. We conducted a scoping review of US-based evidence documenting HbA performance to assess glycemic status among African American, Afro-Caribbean, and African people.

METHODS

A PubMed, Scopus, and Cumulative Index to Nursing and Allied Health Literature (CINAHL) search (January 2020) yielded 3,238 articles published from January 2000 through January 2020. After review of titles, abstracts, and full texts, 12 met our criteria. HbA results were compared with other ethnic groups or validated against the oral glucose tolerance test (OGTT), fasting plasma glucose (FPG), or previous diagnosis. We classified study results by the risk of false positives and risk of false negatives in assessing glycemic status.

RESULTS

In 5 studies of African American people, the HbA test increased risk of false positives compared with White populations, regardless of glycemic status. Three studies of African Americans found that HbA of 5.7% to less than 6.5% or HbA of 6.5% or higher generally increased risk of overdiagnosis compared with OGTT or previous diagnosis. In one study of Afro-Caribbean people, HbA of 6.5% or higher detected fewer type 2 diabetes cases because of a greater risk of false negatives. Compared with OGTT, HbA tests in 4 studies of Africans found that HbA of 5.7% to less than 6.5% or HbA of 6.5% or higher leads to underdiagnosis.

CONCLUSION

HbA criteria inadequately characterizes glycemic status among heterogeneous African descent populations. Research is needed to determine optimal HbA cutoffs or other test strategies that account for risk profiles unique to African American, Afro-Caribbean, and African people living in the United States.

摘要

简介

美国的非裔人群中 2 型糖尿病发病率很高,而且他们经常被错误地归为一个单一的群体。目前的糖化血红蛋白 A(HbA)切点(5.7%至<6.5%为糖尿病前期;≥6.5%为 2 型糖尿病)可能无法在评估非裔人群的血糖状态方面发挥最佳作用。我们对基于美国的证据进行了范围广泛的回顾,以评估 HbA 在评估非裔美国人、 Afro-Caribbean 和非洲人群的血糖状态方面的性能。

方法

通过在 PubMed、Scopus 和 Cumulative Index to Nursing and Allied Health Literature(CINAHL)上进行搜索(2020 年 1 月),从 2000 年 1 月至 2020 年 1 月发表的 3238 篇文章中筛选出符合条件的文章。在对标题、摘要和全文进行审查后,有 12 篇文章符合我们的标准。将 HbA 结果与其他种族群体进行比较,或与口服葡萄糖耐量试验(OGTT)、空腹血浆葡萄糖(FPG)或以前的诊断进行比较。我们根据评估血糖状态时假阳性和假阴性的风险对研究结果进行分类。

结果

在 5 项针对非裔美国人的研究中,HbA 检测与白人相比增加了假阳性的风险,而与血糖状态无关。三项非裔美国人的研究发现,HbA 为 5.7%至<6.5%或 HbA 为 6.5%或更高通常会增加与 OGTT 或以前的诊断相比过度诊断的风险。在一项针对 Afro-Caribbean 人群的研究中,HbA 为 6.5%或更高导致更少的 2 型糖尿病病例,因为假阴性的风险更大。与 OGTT 相比,四项针对非洲人的研究中的 HbA 检测发现,HbA 为 5.7%至<6.5%或 HbA 为 6.5%或更高会导致诊断不足。

结论

HbA 标准不能充分描述美国非裔人群的血糖状态。需要研究确定最佳的 HbA 切点或其他测试策略,以考虑到生活在美国的非裔美国人、 Afro-Caribbean 和非洲人群特有的风险特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/856e/7986971/d19fd524d562/PCD-18-E22s01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验